News

Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB

STOCKHOLM, SE / ACCESSWIRE / November 29, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB (publ) (the "Company" or "Promore")…

7 months ago

MedMira Reports FY2023 Fourth Quarter and Year End Financial Results

HALIFAX, NS / ACCESSWIRE / November 28, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for…

7 months ago

Turkeyana Clinic Continues to Invest in Health Tourism

ISTANBUL, TURKEY / ACCESSWIRE / November 28, 2023 / Turkeyana Clinic, a premier healthcare provider known for its cutting-edge treatments…

7 months ago

1933 Industries Reports Fourth Quarter and 2023 Year-End Financial Results and Posts Record Revenues of $18.3 Million

VANCOUVER, BC / ACCESSWIRE / November 28, 2023 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused…

7 months ago

Saviynt To Demonstrate How Enterprise Identity Cloud Supports Greater Efficiency, Security, and Patient Care at Health-ISAC Summit

LOS ANGELES--(BUSINESS WIRE)--Saviynt, a leading provider of cloud-native identity and governance platform solutions, today announced that it will sponsor the…

7 months ago

Wesana Health Announces Restructuring of Promissory Note Receivable

Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTCQB: WSNAF) (the "Company"), announced…

7 months ago

LevelJump Healthcare Corp. Announces New Preferred Share Offering

Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the…

7 months ago

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi – a Revolutionary Nasal Dry Powder Epinephrine Product

Several key accomplishments completed to finish 2023 and create a strong foundation for 2024.RALEIGH, NC / ACCESSWIRE / November 28,…

7 months ago

Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages

MagnetOs is the first open fibrillar collagen matrix bone graft substitute to receive clearance to market for interbody useMagnetOs can…

7 months ago

LevelJump Healthcare Corp. Declares Quarterly Dividend for Preferred Shareholders

Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the…

7 months ago